ACCEL CLINICAL SERVICES
LIVE

Serial Number

77789409

Owner

Clinical Research Holdings, LLC

Attorney

Mark A. Wright

First Use Date

Aug 1, 2006

Filing Date

Jul 24, 2009

Add to watchlist:

No watchlists yet
View on USPTO

ACCEL CLINICAL SERVICES Trademark

Serial Number: 77789409 • Registration: 3774386

ACCEL CLINICAL SERVICES is a trademark filed by Clinical Research Holdings, LLC on July 24, 2009. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clinical Research Holdings, LLC (5 trademarks)

615 Crescent Executive Court
Lake Mary, FL 32746

Entity Type: 16

Trademark Details

Filing Date

July 24, 2009

Registration Date

April 13, 2010

First Use Anywhere

August 1, 2006

First Use in Commerce

August 10, 2006

Published for Opposition

January 26, 2010

Goods & Services

PROVIDING TRAINING IN THE FIELD OF CLINICAL TRIALS AND CLINICAL TRIAL MANAGEMENT FOR THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES

BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL RESEARCH AND CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, PRE-STUDY DOCUMENT COLLECTION AND REVIEW, SITE SELECTION, VISITS AND AUDITS, SITE COMPLIANCE, PROJECT TRACKING AND MONITORING REPORTS, NEGOTIATION AND ADMINISTRATION OF INVESTIGATOR GRANTS AND CLINICAL TRIAL BUDGETS AND CONTRACTS, FINANCIAL AND MANAGEMENT ACCOUNTING, DISTRIBUTION, COORDINATION AND TRACKING OF CLINICAL TRIAL PRODUCTS AND MATERIALS, REGULATORY DOCUMENT PROCESSING, LABORATORY SELECTION AND COORDINATION; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING SITE AND STUDY-SPECIFIC SUBJECT RECRUITMENT STRATEGIES AND PROGRAMS IN THE NATURE OF CONTINGENCY STRATEGIES AND SOLUTIONS TO ADDRESS SPECIFIC PROJECT CHALLENGES; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING THE DEVELOPMENT OF ALL STUDY RELATED DOCUMENTS AND MATERIALS IN THE NATURE OF STUDY PROTOCOLS, CONTRACTS, BUDGETS, AMENDMENTS, PAPER AND ELECTRONIC CASE REPORT FORMS, INFORMED CONSENT FORMS, SAFETY NARRATIVES, PRESENTATION POSTERS, AND TRAINING MANUALS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING ALL ASPECTS OF STUDY, DRUG RECONCILIATION, AND INVENTORY AND DISTRIBUTION REPORTS, MANAGING ALL ASPECTS OF CLINICAL TRIALS, NAMELY, MANAGING INVESTIGATORS, COORDINATORS, MONITORS, TECHNICIANS, AND PARTICIPANTS, ETHICAL REVIEWS, INVESTIGATOR MEETINGS, DATABASES, STATISTICAL ANALYSES AND REPORTING, RANDOMIZATION LOGISTICS, RECRUITMENT OF INVESTIGATORS, COORDINATORS, MONITORS, TECHNICIANS AND PARTICIPANTS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PHASE ONE THROUGH PHASE FOUR ADMINISTRATION OF CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, THE ADMINISTRATION OF PROTOCOLS INVOLVING VOLUNTEER RESEARCH PATIENTS AND THE RECRUITING OF SUCH VOLUNTEER RESEARCH PATIENTS; PROVIDING DATA MANAGEMENT SERVICES IN THE MEDICAL, PHARMACEUTICAL AND BIOTECHNOLOGICAL FIELD

REGULATORY AFFAIRS, NAMELY, REVIEWING STANDARDS AND PRACTICES TO ASSURE COMPLIANCE WITH CLINICAL TRIAL LAWS AND REGULATIONS

MEDICAL AND SCIENTIFIC RESEARCH CONSULTING REGARDING PRECLINICAL TO PHASE FOUR CLINICAL TRIALS; PROVIDING QUALITY ASSURANCE SERVICES IN THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 29, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 29, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 29, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 29, 2024 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 5, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 5, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 5, 2021 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 5, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 12, 2020 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 13, 2019 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 7, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 7, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 7, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 28, 2016 E815
REGISTERED-PRINCIPAL REGISTER
Apr 13, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 26, 2010 NPUB
PUBLISHED FOR OPPOSITION
Jan 26, 2010 PUBO
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 18, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 5, 2009 PREV
ASSIGNED TO LIE
Dec 5, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 18, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 18, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 18, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 18, 2009 CNEA
FAX RECEIVED
Nov 6, 2009 FAXX
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 4, 2009 GNRN
NON-FINAL ACTION E-MAILED
Nov 4, 2009 GNRT
NON-FINAL ACTION WRITTEN
Nov 4, 2009 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2009 NWOS
NEW APPLICATION ENTERED
Jul 28, 2009 NWAP